Clinical trials
Terminated Phase 2 trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Afimmune | 2 |
| Dompé Farmaceutici S.p.A | 2 |
| Regeneron Pharmaceuticals | 2 |
| AnaptysBio, Inc. | 1 |
| Arsanis, Inc. | 1 |
| Ascendis Pharma A/S | 1 |
| Biogen | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Debiopharm International SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Crohn Disease | 4 |
| Inflammatory Bowel Diseases | 2 |
| Acneiform Eruptions | 1 |
| Acute-On-Chronic Liver Failure | 1 |
| Asthma | 1 |
| COVID-19 | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.